• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

界定中性粒细胞与淋巴细胞比值在慢性阻塞性肺疾病中的作用:一项系统文献综述

Defining the role of neutrophil-to-lymphocyte ratio in COPD: a systematic literature review.

作者信息

Pascual-González Yuliana, López-Sánchez Marta, Dorca Jordi, Santos Salud

机构信息

Department of Respiratory Medicine, Bellvitge University Hospital - IDIBELL, University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain,

Biomedical Research Networking Center Consortium - Respiratory Diseases (CIBERES), Barcelona, Spain,

出版信息

Int J Chron Obstruct Pulmon Dis. 2018 Nov 5;13:3651-3662. doi: 10.2147/COPD.S178068. eCollection 2018.

DOI:10.2147/COPD.S178068
PMID:30464448
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6225854/
Abstract

COPD is characterized by a pulmonary and systemic inflammatory process. Several authors have reported the elevation of multiple inflammatory markers in patients with COPD; however, their use in routine clinical practice has limitations. The neutrophil-to-lymphocyte ratio (NLR) is a useful and cost-effective inflammatory marker derived from routine complete blood count. We performed a systematic literature review using the PRISMA statement. Twenty-two articles were included, recruiting 7,601 COPD patients and 784 healthy controls. Compared with controls, COPD patients had significantly higher NLR values. We found a significant correlation between the NLR and clinical/functional parameters (FEV, mMRC, and BODE index) in COPD patients. Elevation of the NLR is associated with the diagnosis of acute exacerbation of COPD (pooled data propose a cut-off value of 3.34 with a median sensitivity, specificity, and area under the curve of 80%, 86%, and 0.86, respectively). Additionally, increased NLR is also associated with the diagnosis of a bacterial infection in exacerbated patients, with a cut-off value of 7.30, although with a low sensitivity and specificity. The NLR is an independent predictor of in-hospital and late mortality after exacerbation. In conclusion, the NLR could be a useful marker in COPD patients; however, further studies are needed to better identify the clinical value of the NLR.

摘要

慢性阻塞性肺疾病(COPD)的特征是肺部和全身的炎症过程。几位作者报告了COPD患者多种炎症标志物的升高;然而,它们在常规临床实践中的应用存在局限性。中性粒细胞与淋巴细胞比值(NLR)是一种从常规全血细胞计数得出的有用且经济高效的炎症标志物。我们使用PRISMA声明进行了系统的文献综述。纳入了22篇文章,招募了7601例COPD患者和784例健康对照。与对照组相比,COPD患者的NLR值显著更高。我们发现COPD患者的NLR与临床/功能参数(FEV、mMRC和BODE指数)之间存在显著相关性。NLR升高与COPD急性加重的诊断相关(汇总数据提出的截断值为3.34,中位敏感性、特异性和曲线下面积分别为80%、86%和0.86)。此外,NLR升高也与加重患者细菌感染的诊断相关,截断值为7.30,尽管敏感性和特异性较低。NLR是加重后住院和晚期死亡率的独立预测因子。总之,NLR可能是COPD患者的一个有用标志物;然而,需要进一步研究以更好地确定NLR的临床价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8bc/6225854/8f929a4379dd/copd-13-3651Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8bc/6225854/09f9fda889fe/copd-13-3651Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8bc/6225854/8f929a4379dd/copd-13-3651Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8bc/6225854/09f9fda889fe/copd-13-3651Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8bc/6225854/8f929a4379dd/copd-13-3651Fig2.jpg

相似文献

1
Defining the role of neutrophil-to-lymphocyte ratio in COPD: a systematic literature review.界定中性粒细胞与淋巴细胞比值在慢性阻塞性肺疾病中的作用:一项系统文献综述
Int J Chron Obstruct Pulmon Dis. 2018 Nov 5;13:3651-3662. doi: 10.2147/COPD.S178068. eCollection 2018.
2
Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients.慢性阻塞性肺疾病患者病情稳定期和急性加重期中性粒细胞与淋巴细胞比值的变化
Clin Respir J. 2017 May;11(3):311-317. doi: 10.1111/crj.12336. Epub 2015 Aug 6.
3
The Neutrophil to Lymphocyte Ratio Is Related to Disease Severity and Exacerbation in Patients with Chronic Obstructive Pulmonary Disease.中性粒细胞与淋巴细胞比值与慢性阻塞性肺疾病患者的疾病严重程度及病情加重有关。
Intern Med. 2016;55(3):223-9. doi: 10.2169/internalmedicine.55.5772. Epub 2016 Feb 1.
4
Eosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: neutrophil-to-lymphocyte ratio as an exacerbation marker.伴有慢性呼吸衰竭的嗜酸性粒细胞性和非嗜酸性粒细胞性慢性阻塞性肺疾病患者:中性粒细胞与淋巴细胞比值作为病情加重的标志物
Int J Chron Obstruct Pulmon Dis. 2017 Nov 23;12:3361-3370. doi: 10.2147/COPD.S147261. eCollection 2017.
5
The neutrophil/lymphocyte ratio is a better addition to C-reactive protein than CD64 index as a marker for infection in COPD.中性粒细胞/淋巴细胞比值作为 COPD 感染的标志物,优于 CD64 指数,是 C-反应蛋白的更好补充。
Panminerva Med. 2017 Sep;59(3):203-209. doi: 10.23736/S0031-0808.17.03296-7. Epub 2017 Feb 9.
6
Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Monocyte-to-Lymphocyte Ratio (MLR) as Biomarkers in Diagnosis Evaluation of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Retrospective, Observational Study.中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)及单核细胞与淋巴细胞比值(MLR)作为慢性阻塞性肺疾病急性加重诊断评估的生物标志物:一项回顾性观察研究
Int J Chron Obstruct Pulmon Dis. 2024 Apr 15;19:933-943. doi: 10.2147/COPD.S452444. eCollection 2024.
7
Usefulness of neutrophil to lymphocyte ratio in patients with chronic obstructive pulmonary disease: a prospective observational study.中性粒细胞与淋巴细胞比值在慢性阻塞性肺疾病患者中的应用价值:一项前瞻性观察研究。
Korean J Intern Med. 2016 Sep;31(5):891-8. doi: 10.3904/kjim.2015.084. Epub 2016 Mar 25.
8
Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值对慢性阻塞性肺疾病急性加重患者院内死亡率的预后作用
Int J Chron Obstruct Pulmon Dis. 2017 Aug 3;12:2285-2290. doi: 10.2147/COPD.S141760. eCollection 2017.
9
The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia.炎症标志物在预测伴或不伴嗜酸性粒细胞增多的慢性阻塞性肺疾病(COPD)病例再入院率和死亡率方面的效用。
Int J Chron Obstruct Pulmon Dis. 2015 Nov 11;10:2469-78. doi: 10.2147/COPD.S90330. eCollection 2015.
10
Can we predict the prognosis of COPD with a routine blood test?我们能否通过常规血液检查预测慢性阻塞性肺疾病(COPD)的预后?
Int J Chron Obstruct Pulmon Dis. 2017 Feb 13;12:615-625. doi: 10.2147/COPD.S124041. eCollection 2017.

引用本文的文献

1
Non-linear association between neutrophil-to-lymphocyte ratio and 90-day mortality in patients with pneumonia receiving glucocorticoids alone or in combination with other immunosuppressants: A retrospective cohort study.单独使用糖皮质激素或联合其他免疫抑制剂治疗的肺炎患者中,中性粒细胞与淋巴细胞比值与90天死亡率之间的非线性关联:一项回顾性队列研究。
PLoS One. 2025 Aug 18;20(8):e0329616. doi: 10.1371/journal.pone.0329616. eCollection 2025.
2
Relationship between systemic immune response index (SIRI) and COPD: a cross-sectional study based on NHANES 2007-2012.全身免疫反应指数(SIRI)与慢性阻塞性肺疾病(COPD)的关系:一项基于2007 - 2012年美国国家健康与营养检查调查(NHANES)的横断面研究。
Sci Rep. 2025 Mar 6;15(1):7887. doi: 10.1038/s41598-025-90947-8.
3

本文引用的文献

1
The Importance of Neutrophil-to-Lymphocyte Ratio in Chronic Obstructive Pulmonary Disease.中性粒细胞与淋巴细胞比值在慢性阻塞性肺疾病中的重要性
Turk Thorac J. 2016 Apr;17(2):41-46. doi: 10.5578/ttj.17.2.009. Epub 2016 Apr 1.
2
An Increased Proportion of Apoptosis in CD4⁺ T Lymphocytes Isolated from the Peripheral Blood in Patients with Stable Chronic Obstructive Pulmonary Disease.稳定期慢性阻塞性肺疾病患者外周血分离出的CD4⁺ T淋巴细胞凋亡比例增加。
Tuberc Respir Dis (Seoul). 2018 Apr;81(2):132-137. doi: 10.4046/trd.2017.0079. Epub 2018 Jan 24.
3
Study of inflammatory markers and BODE index in chronic obstructive pulmonary disease.
CRP, Fibrinogen, White Blood Cells, and Blood Cell Indices as Prognostic Biomarkers of Future COPD Exacerbation Frequency: The TIE Cohort Study.CRP、纤维蛋白原、白细胞和血细胞指数作为慢性阻塞性肺疾病(COPD)未来急性加重频率的预后生物标志物:TIE队列研究
J Clin Med. 2024 Jun 30;13(13):3855. doi: 10.3390/jcm13133855.
4
The association of systemic immune-inflammation index with lung function, risk of COPD and COPD severity: A population-based study.系统免疫炎症指数与肺功能、COPD 风险和 COPD 严重程度的相关性:一项基于人群的研究。
PLoS One. 2024 Jun 14;19(6):e0303286. doi: 10.1371/journal.pone.0303286. eCollection 2024.
5
Neutrophil-to-Lymphocyte Ratio and Blood Eosinophil Levels As Inflammatory Indicators in Smoker and Non-smoker Young Adult Patients With Chronic Obstructive Pulmonary Disease at a Tertiary Care Hospital.三级护理医院中吸烟和不吸烟的年轻成年慢性阻塞性肺疾病患者中性粒细胞与淋巴细胞比值及血嗜酸性粒细胞水平作为炎症指标的研究
Cureus. 2024 Mar 15;16(3):e56212. doi: 10.7759/cureus.56212. eCollection 2024 Mar.
6
Systematic Review of the Association of the Hospital Frailty Risk Score with Mortality in Patients with Cerebrovascular and Cardiovascular Disease.系统评价医院衰弱风险评分与脑血管病和心血管病患者死亡率的关系。
Curr Cardiol Rev. 2024;20(3):45-62. doi: 10.2174/011573403X276647240217112151.
7
The role of neutrophil to lymphocyte ratio in patients with COPD-OSA overlap syndrome.中性粒细胞与淋巴细胞比值在 COPD-OSA 重叠综合征患者中的作用。
Sleep Breath. 2024 Jun;28(3):1329-1335. doi: 10.1007/s11325-024-03013-4. Epub 2024 Feb 28.
8
Optimizing inhaled corticosteroid use in patients with chronic obstructive pulmonary disease: assessing blood eosinophils, neutrophil-to-lymphocyte ratio, and mortality outcomes in US adults.优化慢性阻塞性肺疾病患者吸入性皮质类固醇的使用:评估美国成年人血液嗜酸性粒细胞、中性粒细胞与淋巴细胞比值和死亡率结局。
Front Immunol. 2023 Nov 15;14:1230766. doi: 10.3389/fimmu.2023.1230766. eCollection 2023.
9
Haematological and Inflammatory Biomarkers Among Stable COPD and Acute Exacerbations of COPD Patients.稳定期 COPD 患者和 COPD 急性加重患者的血液学和炎症生物标志物。
Sultan Qaboos Univ Med J. 2023 May;23(2):239-244. doi: 10.18295/squmj.12.2022.062. Epub 2023 May 31.
10
Prognostic Value of Neutrophil to Lymphocyte Ratio for Predicting 90-Day Poor Outcomes in Hospitalized Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.中性粒细胞与淋巴细胞比值对预测慢性阻塞性肺疾病急性加重住院患者 90 天不良预后的预测价值。
Int J Chron Obstruct Pulmon Dis. 2023 Jun 14;18:1219-1230. doi: 10.2147/COPD.S399671. eCollection 2023.
慢性阻塞性肺疾病中炎症标志物与BODE指数的研究
Lung India. 2018 Jan-Feb;35(1):37-40. doi: 10.4103/lungindia.lungindia_46_17.
4
Recommendations for assessing the risk of bias in systematic reviews of health-care interventions.评估卫生保健干预措施系统评价中偏倚风险的建议。
J Clin Epidemiol. 2018 May;97:26-34. doi: 10.1016/j.jclinepi.2017.12.004. Epub 2017 Dec 14.
5
Eosinophilic and non-eosinophilic COPD patients with chronic respiratory failure: neutrophil-to-lymphocyte ratio as an exacerbation marker.伴有慢性呼吸衰竭的嗜酸性粒细胞性和非嗜酸性粒细胞性慢性阻塞性肺疾病患者:中性粒细胞与淋巴细胞比值作为病情加重的标志物
Int J Chron Obstruct Pulmon Dis. 2017 Nov 23;12:3361-3370. doi: 10.2147/COPD.S147261. eCollection 2017.
6
Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值对慢性阻塞性肺疾病急性加重患者院内死亡率的预后作用
Int J Chron Obstruct Pulmon Dis. 2017 Aug 3;12:2285-2290. doi: 10.2147/COPD.S141760. eCollection 2017.
7
Value of neutrophil-to-lymphocyte ratio for predicting lung cancer prognosis: A meta-analysis of 7,219 patients.中性粒细胞与淋巴细胞比值对预测肺癌预后的价值:7219例患者的荟萃分析
Mol Clin Oncol. 2017 Sep;7(3):498-506. doi: 10.3892/mco.2017.1342. Epub 2017 Jul 24.
8
Evaluation of platelet lymphocyte ratio and 90-day mortality in patients with acute exacerbation of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重患者血小板淋巴细胞比值与90天死亡率的评估
J Thorac Dis. 2017 Jun;9(6):1509-1516. doi: 10.21037/jtd.2017.05.77.
9
Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重患者入院时中性粒细胞与淋巴细胞比值与预后的关系。
Tuberk Toraks. 2017 Mar;65(1):25-31.
10
Blood and sputum eosinophils in COPD; relationship with bacterial load.慢性阻塞性肺疾病中的血液和痰液嗜酸性粒细胞;与细菌载量的关系。
Respir Res. 2017 May 8;18(1):88. doi: 10.1186/s12931-017-0570-5.